DE69529910D1 - Zellen, die einen cd4-scheinrezeptor tragen und entsprechende moleküle und verfahren - Google Patents

Zellen, die einen cd4-scheinrezeptor tragen und entsprechende moleküle und verfahren

Info

Publication number
DE69529910D1
DE69529910D1 DE69529910T DE69529910T DE69529910D1 DE 69529910 D1 DE69529910 D1 DE 69529910D1 DE 69529910 T DE69529910 T DE 69529910T DE 69529910 T DE69529910 T DE 69529910T DE 69529910 D1 DE69529910 D1 DE 69529910D1
Authority
DE
Germany
Prior art keywords
cells carrying
hiv
receptors
corresponding molecules
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69529910T
Other languages
English (en)
Other versions
DE69529910T2 (de
Inventor
Brian Seed
Babak Banapour
Charles Romeo
Waldemar Kolanus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,391 external-priority patent/US5851828A/en
Priority claimed from US08/394,388 external-priority patent/US6753162B1/en
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE69529910D1 publication Critical patent/DE69529910D1/de
Application granted granted Critical
Publication of DE69529910T2 publication Critical patent/DE69529910T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69529910T 1994-08-02 1995-07-26 Zellen, die einen cd4-scheinrezeptor tragen und entsprechende moleküle und verfahren Expired - Lifetime DE69529910T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/284,391 US5851828A (en) 1991-03-07 1994-08-02 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US08/394,388 US6753162B1 (en) 1991-03-07 1995-02-24 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
PCT/US1995/009468 WO1996003883A1 (en) 1994-08-02 1995-07-26 Cells bearing cd4 decoy receptors and related molecules and methods

Publications (2)

Publication Number Publication Date
DE69529910D1 true DE69529910D1 (de) 2003-04-17
DE69529910T2 DE69529910T2 (de) 2003-12-18

Family

ID=26962581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529910T Expired - Lifetime DE69529910T2 (de) 1994-08-02 1995-07-26 Zellen, die einen cd4-scheinrezeptor tragen und entsprechende moleküle und verfahren

Country Status (22)

Country Link
EP (1) EP0781095B1 (de)
JP (1) JP3832856B2 (de)
KR (1) KR100384249B1 (de)
CN (1) CN1142941C (de)
AT (1) ATE234011T1 (de)
AU (1) AU697489B2 (de)
CA (1) CA2195653C (de)
CZ (1) CZ293943B6 (de)
DE (1) DE69529910T2 (de)
DK (1) DK0781095T3 (de)
ES (1) ES2191058T3 (de)
FI (1) FI119868B (de)
HK (1) HK1002545A1 (de)
HU (1) HU221603B (de)
IL (1) IL114778A (de)
MX (1) MX9700800A (de)
NO (1) NO325081B1 (de)
NZ (1) NZ291017A (de)
PL (1) PL181085B1 (de)
PT (1) PT781095E (de)
UA (1) UA45349C2 (de)
WO (1) WO1996003883A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
JP4704565B2 (ja) * 1998-09-23 2011-06-15 ザイモジェネティクス， インコーポレイテッド サイトカインレセプターｚａｌｐｈａ１１
RU2746486C2 (ru) * 2015-03-13 2021-04-14 Юниверсити Оф Мэрилэнд, Балтимор Универсальный антителоопосредованный биосенсор
MX2018001502A (es) 2015-08-05 2018-08-01 Yoo Young Pharm Co Ltd Receptor de antigeno quimerico y celulas t en las cuales se expresa el receptor de antigeno quimerico.
CA2999496A1 (en) * 2015-09-22 2017-03-30 The Trustees Of The University Of Pennsylvania Method of redirecting t cells to treat hiv infection
US20220348677A1 (en) * 2019-09-24 2022-11-03 The Regents Of The University Of California Receptors with heterologous transmembrane domain
AU2020355031A1 (en) * 2019-09-24 2022-05-19 The Regents Of The University Of California Notch receptors with hinge domain
WO2021061809A1 (en) * 2019-09-24 2021-04-01 The Regents Of The University Of California Novel receptors having a fibronectin repeat for ligand-dependent transcriptional regulation
EP4034255A4 (de) * 2019-09-24 2023-11-08 The Regents Of The University Of California Notch-rezeptoren mit minimalem linker
CN112176037A (zh) * 2020-09-24 2021-01-05 深圳普瑞金生物药业有限公司 检测car-t细胞目的基因拷贝数的方法、引物对、探针及试剂盒
EP4112639A1 (de) * 2021-07-02 2023-01-04 Universitat de Barcelona Car-t/nk-zellen zur verwendung bei der behandlung von invasiven pilzinfektionen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6463394A (en) * 1987-09-04 1989-03-09 Kyowa Hakko Kogyo Kk Novel chimera polypeptide
ZA89430B (en) * 1988-01-22 1989-10-25 Gen Hospital Corp Cloned genes encoding ig-cd4 fusion proteins and the use thereof
NZ241855A (en) * 1991-03-07 1994-04-27 Gen Hospital Corp Use of therapeutic cells to obtain cellular response to infection, tumours or autoimmune-generated cells, cells with chimaeric receptors (with binding component and destruction signal), dna encoding the receptor, vectors and antibodies to receptor
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells

Also Published As

Publication number Publication date
WO1996003883A1 (en) 1996-02-15
JPH10503932A (ja) 1998-04-14
EP0781095B1 (de) 2003-03-12
PL318443A1 (en) 1997-06-09
KR100384249B1 (ko) 2003-08-30
ES2191058T3 (es) 2003-09-01
CZ293943B6 (cs) 2004-08-18
JP3832856B2 (ja) 2006-10-11
IL114778A (en) 2008-08-07
EP0781095A1 (de) 1997-07-02
KR970704357A (ko) 1997-09-06
FI970428A0 (fi) 1997-01-31
CZ26497A3 (en) 1997-10-15
CA2195653A1 (en) 1996-02-15
HUT77253A (hu) 1998-03-02
FI970428A (fi) 1997-03-26
DK0781095T3 (da) 2003-06-23
PT781095E (pt) 2003-06-30
NZ291017A (en) 1998-05-27
UA45349C2 (uk) 2002-04-15
PL181085B1 (pl) 2001-05-31
EP0781095A4 (de) 1999-03-03
NO970440D0 (no) 1997-01-31
AU697489B2 (en) 1998-10-08
CN1142941C (zh) 2004-03-24
IL114778A0 (en) 1995-11-27
NO325081B1 (no) 2008-01-28
HK1002545A1 (en) 1998-09-04
FI119868B (fi) 2009-04-30
NO970440L (no) 1997-03-26
MX9700800A (es) 1997-11-29
CA2195653C (en) 2010-04-27
CN1158552A (zh) 1997-09-03
HU221603B (hu) 2002-11-28
DE69529910T2 (de) 2003-12-18
ATE234011T1 (de) 2003-03-15
AU3201495A (en) 1996-03-04

Similar Documents

Publication Publication Date Title
ATE308888T1 (de) Gezielte zell-lyse von hiv-infizierten zellen mit chimären cd4 rezeptortragenden zellen
LUC00057I2 (de)
DE69529910D1 (de) Zellen, die einen cd4-scheinrezeptor tragen und entsprechende moleküle und verfahren
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
ATE439860T1 (de) Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikírpern
ATE552849T1 (de) Behandlungsverfahren unter verwendung von ctla-4 antikörpern
ATE242800T1 (de) Chimäre rezeptorgene und entsprechend damit transformierte zellen
FI973437A (fi) Soluimmuniteetin uudelleenkohdistus reseptorikimeerien avulla
DE69535501D1 (de) Identifikation, reinigung und verwendungen von leczymen und karbohydratliganden
DE69631624D1 (de) Antikörper gegen menschliches restrictin
ATE309371T1 (de) Protein mit dnase-aktivität
DE69227618T2 (de) Die verwendung des leukozyten adhäsionsmolekül-1- aus endothelzellen und antikörper dagegen in der behandlung von asthma
ATE391913T1 (de) Peptidepitope die von krankheitsfördernden cd4+ t lymphocyten erkannt werden
NZ330034A (en) Method of treating HIV in mammals by administering cells bearing CD4 decoy receptors
RU97103190A (ru) Способы создания клеток, несущих cd4-рецепторные ловушки и родственные молекулы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition